Should You Buy AbbVie Stock Hand Over Fist Before April 29? [Globe and Mail, The (Toronto, Canada)]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Globe and Mail, The
Some of the drugmaker's other products might not perform well. AbbVie's underlying business and dividend program still make the stock attractive. AbbVie (NYSE: ABBV) , a pharmaceutical giant, is set to release its first-quarter earnings report on April 29. The stock has not performed well so far this year, with shares down 13% as of writing. Could the drugmaker's quarterly update be the catalyst that helps it recover? Let's find out whether it's worth it to invest in AbbVie before its next earnings report. What will the earnings report reveal? AbbVie is entering its quarterly update with solid momentum for its key growth pillars, Skyrizi and Rinvoq. These two immunology medicines have replaced Humira, once the world's best-selling drug, whose revenue peaked at $21.2 billion. The pharmaceutical leader is projecting that Skyrizi and Rinvoq will cross $31 billion in combined annual sales in 2026, one year ahead of schedule. The market will expect strong first-quarter performance
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie Raises 2026 Outlook Following First-Quarter Beat on Immunology Growth [Yahoo! Finance]Yahoo! Finance
- AbbVie Reports First-Quarter 2026 Financial Results [TheStreet.com]TheStreet.com
- AbbVie Reports First-Quarter 2026 Financial ResultsPR Newswire
- Should You Buy AbbVie Stock Hand Over Fist Before April 29? [Yahoo! Finance]Yahoo! Finance
- AbbVie (ABBV) To Report Earnings Tomorrow: Here Is What To Expect [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/29/26 - Beat
ABBV
Sec Filings
- 4/29/26 - Form SCHEDULE
- 4/29/26 - Form 8-K
- 4/3/26 - Form 8-K
- ABBV's page on the SEC website